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Commentary
Two speedier phenotypic methods on drug susceptibility
testing of Mycobacterium tuberculosis
The introduction of drugs beginning with
streptomycin for the treatment of tuberculosis (TB)
and the subsequent emergence of drug resistant
Mycobacterium tuberculosis strains has made the
testing for susceptibility of the latter a basic necessity.
The World Health Organization (WHO) recognized
the importance of these laboratory issues even in the
early sixties and conducted extensive studies by
involving laboratories from both disease endemic
developing countries (DEDCs) and disease non
endemic countries to standardize the susceptibility
(DEDCs) testing procedures for M. tuberculosis for
all the three methods that were in vogue, viz., absolute
concentration method, resistance ratio method (RR)
and the proportion susceptibility testing method (PST).
Two reports by Canetti et al1,2 at different periods
delineated in precise terms the criteria of resistance
by all these three methods and recommended
Lowenstein-Jenson (LJ) medium as the standard
culture medium for any susceptibility testing. The
resurgence of TB worldwide in the recent past has
been accompanied by an increase in the incidence of
drug resistant TB, notably multi drug resistant
tuberculosis (MDR - TB), i.e., strains resistant to at
least isoniazid (INH) and rifampicin. Since the
dreadful combination of TB with human
immunodeficiency virus (HIV) infection, spread of
MDR-TB with a global increase in HIV infection at
the same time has become a major public health
problem. In particular, in DEDCs; it has become a
necessity to invent simple, rapid identification and
susceptibility testing of such suspected resistant
isolates. The newer rapid automated liquid culture
methods such as BACTEC 460 TB, MGIT960, MB
Bact etc., along with probe based methods of
identification of species and detection of drug
resistance with low turn around time are routinely
available in most of the developed countries3. In
DEDCs, such an approach is simply not feasible since
there exists a considerable resource constraints both
in terms of manpower and materials. However, in this
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setting, rapid diagnosis of resistance to the  two key
drugs, namely INH and rifampicin, is vital for the
management of MDR-TB patients. In this context,
developing low cost, speedier, at the same time
technically less demanding simpler methods for the
detection of resistant strains cannot be
overemphasized.
As early as 1969 and 1970, promising results were
published from the Tuberculosis Research Centre,
Chennai of direct sensitivity tests from the
concentrated sputum deposit and also by a swab
culture method that can be performed even without
the use of a centrifuge4. Later, a number of low cost
colorimetric antimicrobial susceptibility testing of
M. tuberculosis assays such as tetrazolium bromide
(MTT assay), alamar blue assay, nitrate reductase
assay  and other simpler methods such as microscopic
detection of cord-like growth (MODS) and E tests
were developed and applied successfully in these
settings5. However, these assays may have basic
limitations since Mycobacteria other than tuberculosis
(MOTT) can also produce cord factor and INH can
interfere with formazan production in MTT assay and
give rise to false resistant results. Besides, use of
liquid medium in microtitre plates is associated with
biohazard and cross contamination, and E test requires
technical expertise in the preparation of inoculum for
seeding and the danger of aerosol spread if not carried
out in biosafety cabinets. One of the recent rapid
techniques i.e., the nitrate reductase assay is based
on the biochemical properties of M. tuberculosis to
reduce the nitrate to nitrite in the substrate by using
the nitrate reductase enzyme. Since most of the
nonpathogenic mycobacteria lack this enzyme, the
detection of  M.tuberculosis is fairly accurate by this
method. The presence of nitrite is detected by a colour
change to pink upon addition of specific reagents that
can be seen visually. The test is simple, rapid and is
highly reproducible and fairly comparable to the
BACTEC 460 TB system, in detecting MDR-TB
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strains, and they are also equally rapid in that results
are available within 7-14 days3. It can be done in most
laboratories, having facility for culture and does not
require any expensive reagents or chemicals. Like-
wise, the  E test also can be performed in laboratories
where culture facilities are already available5.
However, unlike direct susceptibility test, growth of
organisms is required for the performance of both
these tests. And also at least one identification test
method must be employed along with these tests to
differentiate M. tuberculosis.
Although all these phenotypic methods as referred
in this issue by Sethi et al6 and Sumathi et al7 may
yield a quick answer in determining resistance, none
of these are one hundred per cent perfect like PST
method1. That is why the WHO advocates PST as a
standard method for the conduction of global drug
resistance surveillance with an External Quality
Assurance Programme8. Efforts are underway in
strengthening Mycobacteriology laboratory services
in India. The Indian Council of Medical Research has
taken up a lead in establishing good quality laboratory
services in eight medical colleges in India with India
Clen (INCLEN) initiative by allowing Tuberculosis
Research Centre (TRC), Chennai to take part in this
activity. Likewise, TRC is also serving as a National
Reference Centre and also as a WHO Supra National
Reference Laboratory (SNRL) for this region in
streamlining the drug susceptibility testing activities
as a part of its goal in strengthening laboratory
services.
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